Serigen Mediproducts has developed products that can be used to fill cavities in bone or bandage non-healing wounds ...

In a report released on November 6, Brian Skorney from Robert W. Baird maintained a Hold rating on Arbutus Biopharma (ABUS – Research ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & DevelopmentPresentations and seminars ...

Investigators from UB’s CTSI were among those from several institutions who were recently awarded a two-year, $2.1 million grant from NCATS.

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

WuXi XDC Cayman Inc. ('WuXi XDC' or the 'Company', stock code: 2268.HK), a leading global CRDMO (Contract Research, ...

The project includes the establishment of a Research and Innovation Centre. Construction has commenced on the redevelopment ...

Hoa Lac Stem Cell JSC (HSC) held a groundbreaking ceremony for the HSC Stem Cell Technology Platform (HOSTEP) at Hoa Lac ...

The NET exam, conducted twice yearly, determines eligibility for assistant professor positions and junior research ...

Introduction Postpartum haemorrhage (PPH) remains the leading cause of maternal death. Yet there is a lack of clarity around ...

NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

TD Cowen analyst Tyler Van Buren maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report) today and set a price target of $20.00. Tyler Van Buren’s rating is based on EyePoint ...